Back

Overview

Advice

Overview Wealth Planning Portfolio Management

Invest

Overview Shares & ETF’s Bonds Capital Protected Investments Funds Corporate Finance Investments

Committed to you, your financial future, and your journey there

Overview Investment Solutions Pension Solutions SDIO Application Forms – Intermediaries

Creating impact for your clients, their financial goals, and their future

Overview

Cantor Fitzgerald Asset Management

Overview Market Updates Useful Forms Sustainability Disclosures
Fund Centre

Multi-Asset Funds

Overview Multi-Asset 70 Fund Multi-Asset 50 Fund Multi-Asset 30 Fund Balanced Fund

Equity Funds

Overview Irish Equity Fund International Equity Fund International Equity UCITS Fund Global Equity Income Fund

ESG/Ethical Funds

Overview Green Effects Fund Paris Aligned Global Equity Fund Ethical Fund Ethical International Fund

Thematic Funds

Overview Technology Fund Infrastructure Impact Fund New Haven Housing Fund

Absolute Return Fund

Alternative Investment Fund (QIAIF) Alternative Investment Fund (RIAIF)

Fixed Income & Cash Funds

Overview Cash Fund Long Bond Fund Fixed Interest Fund

Our sole objective is to achieve the best investment returns for you

Overview

Corporate

Overview

Real Estate

Overview Capital Markets & Advisory

Focused on your organisation, funding its growth, and unlocking its full potential

Credit Unions

Overview Investment Advisory Services
Debt Capital Markets Probate Services

Dedicated to institutional wealth, stakeholder value, and a sustainable future

Overview Investment Services Stewardship

Supportive of you, your custodial 
vision, and your philanthropic goals

Weekly Trader and Bond Markets 20.05.24 – Roche Holdings, Ryanair & Alphabet

20.05.2024



Opportunities this week:

  • We are reiterating our BUY rating on Roche Holdings following promising Phase 1b trials for its obesity and type 2 diabetes drug. (BUY: CHF280 target)
  • We are reiterating our BUY rating on Ryanair following the airlines FY24 earnings release. (BUY: €23.40 target)
  • We are reiterating our BUY rating on Alphabet following it’s annual I/O developer conference. (BUY: $200 target)